BAILARD, INC. - MARAVAI LIFESCIENCES HLDGS I ownership

MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 210 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of MARAVAI LIFESCIENCES HLDGS I
ValueSharesWeighting
Q3 2022$1,592,000
-17.8%
62,375
-8.5%
0.07%
-13.2%
Q2 2022$1,937,000
-17.0%
68,195
+3.1%
0.08%
-2.6%
Q1 2022$2,333,000
-15.8%
66,135
-0.0%
0.08%
-11.4%
Q4 2021$2,771,000
-13.3%
66,144
+1.5%
0.09%
-19.3%
Q3 2021$3,197,000
+17.6%
65,1400.0%0.11%
+16.0%
Q2 2021$2,718,000
+4.5%
65,140
-10.7%
0.09%
-2.1%
Q1 2021$2,600,00072,9380.10%
Other shareholders
MARAVAI LIFESCIENCES HLDGS I shareholders Q4 2022
NameSharesValueWeighting ↓
GTCR LLC 21,681,033$1,064,105,00026.99%
Ghisallo Capital Management LLC 1,250,000$61,350,0002.33%
Beck Bode, LLC 160,064$7,856,0002.19%
Select Equity Group, L.P. 12,122,011$594,948,300,0002.00%
Pinz Capital Management, LP 83,603$4,103,0001.86%
Monashee Investment Management LLC 185,000$9,080,0001.68%
Ownership Capital B.V. 2,717,559$133,378,0001.51%
Eversept Partners, LP 327,810$16,088,9151.12%
Parkman Healthcare Partners LLC 90,000$4,417,0001.12%
Connacht Asset Management LP 28,569$1,402,0000.91%
View complete list of MARAVAI LIFESCIENCES HLDGS I shareholders